Clinical Study

Atrial Fibrillation Study Testing Ablation Or Drug Therapy

Posted Date: Aug 28, 2013

  • Investigator: Alexandru Costea
  • Co-Investigator: Carol Knochelmann
  • Specialties: Cardiology, Heart Disease, Cardiovascular Disease
  • Type of Study: Drug

Atrial fibrillation (AF) (an abnormal, rapid heart rhythm coming from the upper chambers of the heart [atria]) is the most common type of heart rhythm disorder or arrhythmia (abnormal heart rhythm). Instead of the heart beating in a steady pattern, in AF the upper chambers of the heart (atria) quiver rapidly in an unsteady manner. Atrial fibrillation may be treated with drug therapy designed to either prevent the heart rate from going too fast during atrial fibrillation (rate control therapy) or with drug therapy designed to stop the abnormal rhythm and maintain normal heart beating (rhythm control therapy). In some Institutions, atrial fibrillation is also treated with catheters inserted into blood vessels that can be placed inside the heart to eliminate the hot spots or triggers that start atrial fibrillation or stop those conditions that keep it going (catheter ablation). It is not known whether drug therapy or catheter ablation is better. You are being asked to participate in the Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Study which is being done to compare drug therapy and catheter ablation in participants with atrial fibrillation. This study will help decide which treatment approach is best or when one or the other therapy is preferred. The CABANA study will also compare the cost of care for the two treatment approaches and determine the effect these therapies have on quality of life.

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are 18 Years Of Age And Older And You Have Been Diagnosed With Atrial Fibrillation.

Keywords:

Ablation, Abnormal Heart Rhythm, Arrhythmia, Atrial Fibrillation, Heart Rhythm

For More Information:

Carol Knochelmann
513 558-2273
heart@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.